GENEVA, Sept. 29 -- APTARION BIOTECH AG (Max-Dohrn-Strasse 8-1010589 Berlin) filed a patent application (PCT/EP2025/057730) for "METHOD OF TREATING A DISORDER WITH A C5A INHIBITOR" on Mar 20, 2025. With publication no. WO/2025/196240, the details related to the patent application was published on Sep 25, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KLUSSMANN, Sven (c/o Aptarion biotech AGMax-Dohrn-Strasse 8-1010589 Berlin), VATER, Axel (c/o Aptarion biotech AGMax-Dohrn-Strasse 8-1010589 Berlin), HOHLIG, Kai (c/o Aptarion biotech AGMax-Dohrn-Strasse 8-1010589 Berlin)
Abstract: The present...